A novel drug reduces the monthly frequency of seizure in adults with focal epilepsy Post author: Post published:October 11, 2023 Post category:uncategorized The effect of a novel Kv7.2/Kv7.3 potassium channel opener XEN1101 in reducing monthly seizure frequency in adults. You Might Also Like Study reveals limited access to opioid treatment in US jails September 24, 2024 New discovery in spinal cord neurons offers hope for breathing recovery August 13, 2025 Inside the FDA’s vaccine uproar December 19, 2025